A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes) (N1T-MC-MALO (SYNERGY-Outcomes))

Principal Investigator

Dr Jeremy Cobbold

Contact us

Email: ouh-tr.ctfresearch@nhs.net

IRAS number

1012805